BMO raises DuPont stock price target to $190 on execution strength
BMO Capital raised DuPont's (NYSE:DD) price target to $190 from $186, citing strong execution and growth. The company reported Q3 adjusted earnings of $2.09 per share on $1.9B revenue, exceeding guidance. UBS and Wells Fargo also raised their targets, noting margin strength and increased EBITDA estimates.
How this was made
The 30-second read
Why it matters
Analyst upgrades reinforce bullish bias; price may test higher levels.
Market read
Analyst target hikes suggest near-term upside for DD.
What to watch
Potential headwinds from raw material costs and macro slowdown.
Background
DuPont reported Q3 earnings beat and raised full-year outlook, prompting multiple analyst target upgrades.
Ticker impact
BMO Capital raised DuPont's price target to $190 from $186, citing execution strength and margin improvements.
likely upward pressure as investors price in the higher target.
Target raise reflects improved outlook; market may bid the stock higher.
Market effects
May boost sentiment in specialty chemicals and materials sector.
U.S. market focus; limited regional spillover.
Modest, confined to investors tracking DuPont and peers.
Counterpoint
Target raise could be premature if margin gains stall.
Key entities
- companyDuPont de Nemours Inc.
Specialty chemicals manufacturer.
- analystBMO Capital
Raised price target to $190.



